NIDA Research Monograph, Number 113 [Printed in 1991]
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph113.pdf - Economic Costs, Cost-Effectiveness, Financing, and Community-Based Drug Treatment (1 MB)
Table of Contents
Introduction
Introduction and Summary-----1
William S. Cartwright and James M. Kaple
Economic Costs of Drug Abuse
Economic Costs of Drug Abuse-----10
Dorothy P. Rice, Sander Kelman, and Leonard S. Miller
Economic Cost of Illicit Drug Studies: Critique and
Research Agenda-----33
Jody L. Sindelar
Economics and Drugs: Promises, Problems,
and Prospects-----46
Henrick J. Harwood
Cost-Effectiveness Analysis
Evaluating the Cost-Effectiveness of Drug Abuse
Treatment Services-----57
Robert Apsler
Cost-Effectiveness of Drug Abuse Treatment:
Relevant Issues and Alternative Longitudinal
Modeling Approaches-----67
Yih-lng Hser and M. Douglas Anglin
New Perspectives on the Benefit-Cost and Cost-Effectiveness
of Drug Abuse Treatment-----94
Robert L. Hubbard and Michael T. French
Cost-Effectiveness of Drug Abuse Treatment for Primary
Prevention of Acquired lmmunodeficiency Syndrome:
Epidemiologic Considerations-----114
Thomas M. Lampinen
Financing Services for Drug Abuse Treatment
Policy-Relevant Research on Drug Treatment-----129
Dean R. Gerstein
Community-Based Drug Treatment Reimbursement:
Progress and Barriers-----148
Benjamin C. Duggar
Financing Treatment for Substance Abuse-----165
Mark V. Pauly
Forecasting the Cost of Drug Abuse Treatment Coverage in
Private Health Insurance-----175
Thomas G. McGuire and Barbara F. Shatkin
Health Insurance Coverage Questions, Public Health Surveys,
and Drug Abuse-----190
William S. Cariwright and Albert M. Woodward
Recommendations
Recommendations-----205
William S. Cartwright and James M. Kaple
List of NIDA Research Monographs 212
|
